Context Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Context Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Context Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Context Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $22k | 39k | 0.58 |
| 2026-03-31 | $26k | 10k | 2.45 |
| 2025-03-31 | $49 | 80 | 0.61 |
| 2024-12-31 | $174 | 166 | 1.05 |
| 2024-09-30 | $338 | 173 | 1.96 |
| 2024-03-31 | $45 | 33 | 1.39 |
| 2023-12-31 | $25 | 23 | 1.13 |
| 2023-09-30 | $24 | 16 | 1.50 |